Cancer biotherapy & radiopharmaceuticals
Unlocking Spondin-1 and Spondin-2 as Ultrasound-Responsive Biomarkers in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: Diagnostic and Therapeutic Perspectives.
Hai Ou, Feng Jin, Chenyang Wang, Shubin Wang, Yiwang Ye, Jianming Mo, Fen Wang
Published: 202510.1177/10849785251403920
Abstract
The development of resistance to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) remains a huge challenge in treating EGFR-mutant non-small-cell lung cancer (NSCLC). Recent improvements in ultrasound-based cancer biotherapies…
Preview only. Read the full abstract at the source